| 11. |
- Feigin, Valery L., et al.
(författare)
-
Global, regional, and national burden of stroke and its risk factors, 1990-2019 : a systematic analysis for the Global Burden of Disease Study 2019
- 2021
-
Ingår i: Lancet Neurology. - : Elsevier. - 1474-4422 .- 1474-4465. ; 20:10, s. 795-820
-
Tidskriftsartikel (refereegranskat)abstract
- Background Regularly updated data on stroke and its pathological types, including data on their incidence, prevalence, mortality, disability, risk factors, and epidemiological trends, are important for evidence-based stroke care planning and resource allocation. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) aims to provide a standardised and comprehensive measurement of these metrics at global, regional, and national levels. Methods We applied GBD 2019 analytical tools to calculate stroke incidence, prevalence, mortality, disability-adjusted life-years (DALYs), and the population attributable fraction (PAF) of DALYs (with corresponding 95% uncertainty intervals [UIs]) associated with 19 risk factors, for 204 countries and territories from 1990 to 2019. These estimates were provided for ischaemic stroke, intracerebral haemorrhage, subarachnoid haemorrhage, and all strokes combined, and stratified by sex, age group, and World Bank country income level. Findings In 2019, there were 12.2 million (95% UI 11.0-13.6) incident cases of stroke, 101 million (93.2-111) prevalent cases of stroke, 143 million (133-153) DALYs due to stroke, and 6.55 million (6.00-7.02) deaths from stroke. Globally, stroke remained the second-leading cause of death (11.6% [10.8-12.2] of total deaths) and the third-leading cause of death and disability combined (5.7% [5.1-6.2] of total DALYs) in 2019. From 1990 to 2019, the absolute number of incident strokes increased by 70.0% (67.0-73.0), prevalent strokes increased by 85.0% (83.0-88.0), deaths from stroke increased by 43.0% (31.0-55.0), and DALYs due to stroke increased by 32.0% (22.0-42.0). During the same period, age-standardised rates of stroke incidence decreased by 17.0% (15.0-18.0), mortality decreased by 36.0% (31.0-42.0), prevalence decreased by 6.0% (5.0-7.0), and DALYs decreased by 36.0% (31.0-42.0). However, among people younger than 70 years, prevalence rates increased by 22.0% (21.0-24.0) and incidence rates increased by 15.0% (12.0-18.0). In 2019, the age-standardised stroke-related mortality rate was 3.6 (3.5-3.8) times higher in the World Bank low-income group than in the World Bank high-income group, and the age-standardised stroke-related DALY rate was 3.7 (3.5-3.9) times higher in the low-income group than the high-income group. Ischaemic stroke constituted 62.4% of all incident strokes in 2019 (7.63 million [6.57-8.96]), while intracerebral haemorrhage constituted 27.9% (3.41 million [2.97-3.91]) and subarachnoid haemorrhage constituted 9.7% (1.18 million [1.01-1.39]). In 2019, the five leading risk factors for stroke were high systolic blood pressure (contributing to 79.6 million [67.7-90.8] DALYs or 55.5% [48.2-62.0] of total stroke DALYs), high body-mass index (34.9 million [22.3-48.6] DALYs or 24.3% [15.7-33.2]), high fasting plasma glucose (28.9 million [19.8-41.5] DALYs or 20.2% [13.8-29.1]), ambient particulate matter pollution (28.7 million [23.4-33.4] DALYs or 20.1% [16.6-23.0]), and smoking (25.3 million [22.6-28.2] DALYs or 17.6% [16.4-19.0]). Interpretation The annual number of strokes and deaths due to stroke increased substantially from 1990 to 2019, despite substantial reductions in age-standardised rates, particularly among people older than 70 years. The highest age-standardised stroke-related mortality and DALY rates were in the World Bank low-income group. The fastest-growing risk factor for stroke between 1990 and 2019 was high body-mass index. Without urgent implementation of effective primary prevention strategies, the stroke burden will probably continue to grow across the world, particularly in low-income countries.
|
|
| 12. |
- Ghazy, Ramy Mohamed, et al.
(författare)
-
Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model : A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region
- 2022
-
Ingår i: International Journal of Environmental Research and Public Health. - : MDPI AG. - 1661-7827 .- 1660-4601. ; 19:19
-
Tidskriftsartikel (refereegranskat)abstract
- Coronavirus disease (COVID-19) booster doses decrease infection transmission and disease severity. This study aimed to assess the acceptance of COVID-19 vaccine booster doses in low, middle, and high-income countries of the East Mediterranean Region (EMR) and its determinants using the health belief model (HBM). In addition, we aimed to identify the causes of booster dose rejection and the main source of information about vaccination. Using the snowball and convince sampling technique, a bilingual, self-administered, anonymous questionnaire was used to collect the data from 14 EMR countries through different social media platforms. Logistic regression analysis was used to estimate the key determinants that predict vaccination acceptance among respondents. Overall, 2327 participants responded to the questionnaire. In total, 1468 received compulsory doses of vaccination. Of them, 739 (50.3%) received booster doses and 387 (26.4%) were willing to get the COVID-19 vaccine booster doses. Vaccine booster dose acceptance rates in low, middle, and high-income countries were 73.4%, 67.9%, and 83.0%, respectively (p < 0.001). Participants who reported reliance on information about the COVID-19 vaccination from the Ministry of Health websites were more willing to accept booster doses (79.3% vs. 66.6%, p < 0.001). The leading causes behind booster dose rejection were the beliefs that booster doses have no benefit (48.35%) and have severe side effects (25.6%). Determinants of booster dose acceptance were age (odds ratio (OR) = 1.02, 95% confidence interval (CI): 1.01–1.03, p = 0.002), information provided by the Ministry of Health (OR = 3.40, 95% CI: 1.79–6.49, p = 0.015), perceived susceptibility to COVID-19 infection (OR = 1.88, 95% CI: 1.21–2.93, p = 0.005), perceived severity of COVID-19 (OR = 2.08, 95% CI: 137–3.16, p = 0.001), and perceived risk of side effects (OR = 0.25, 95% CI: 0.19–0.34, p < 0.001). Booster dose acceptance in EMR is relatively high. Interventions based on HBM may provide useful directions for policymakers to enhance the population’s acceptance of booster vaccination.
|
|
| 13. |
- Shaaban, Ramy, et al.
(författare)
-
COVID-19 Vaccine Acceptance among Social Media Users : A Content Analysis, Multi-Continent Study
- 2022
-
Ingår i: International Journal of Environmental Research and Public Health. - : MDPI AG. - 1661-7827 .- 1660-4601. ; 19:9
-
Tidskriftsartikel (refereegranskat)abstract
- Vaccine hesitancy (VH) is defined as a delayed in acceptance or refusal of vaccines despite availability of vaccination services. This multinational study examined user interaction with social media about COVID-19 vaccination. The study analyzed social media comments in 24 countries from five continents. In total, 5856 responses were analyzed; 83.5% of comments were from Facebook, while 16.5% were from Twitter. In Facebook, the overall vaccine acceptance was 40.3%; the lowest acceptance rates were evident in Jordan (8.5%), Oman (15.0%), Senegal (20.0%) and Morocco (20.7%) and the continental acceptance rate was the lowest in North America 22.6%. In Twitter, the overall acceptance rate was (41.5%); the lowest acceptance rate was found in Oman (14.3%), followed by USA (20.5%), and UK (23.3%) and the continental acceptance rate was the lowest in North America (20.5%), and Europe (29.7%). The differences in vaccine acceptance across countries and continents in Facebook and Twitter were statistically significant. Regarding the tone of the comments, in Facebook, countries that had the highest number of serious tone comments were Sweden (90.9%), USA (61.3%), and Thailand (58.8%). At continent level, serious comments were the highest in Asia (58.4%), followed by Africa (46.2%) and South America (46.2%). In Twitter, the highest serious tone was reported in Egypt (72.2%) while at continental level, the highest proportion of serious comments was observed in Asia (59.7%), followed by Europe (46.5%). The differences in tone across countries and continents in Facebook and Twitter and were statistically significant. There was a significant association between the tone and the position of comments. We concluded that the overall vaccine acceptance in social media was relatively low and varied across the studied countries and continents. Consequently, more in-depth studies are required to address causes of such VH and combat infodemics.
|
|
| 14. |
- Abdelmoniem, Amr M., et al.
(författare)
-
Synthesis, Chemistry and Utilities of Diaminoazoles with Special Reference to 3,5-Diaminopyrazoles
- 2018
-
Ingår i: Current Organic Synthesis. - : BENTHAM SCIENCE PUBL LTD. - 1570-1794 .- 1875-6271. ; 15:4, s. 487-514
-
Forskningsöversikt (refereegranskat)abstract
- Background: Although the chemistry of heteroaromatic monoamino azoles has been surveyed more than once in the last decade, the chemistry of the di- and triaminoazoles has not been reviewed. In this article we will survey the synthesis, chemistry and utility of the diaminoazoles. In this review, the chemistry of the diaminoazoles as well as their most important utilities will be surveyed. Objective: The review focuses on recent progress in diaminoazoles (i.e. diaminopyrazoles, diaminoimidazoles, diaminotriazoles and diaminothiazole) with especial references to diaminopyrazoles. The synthesis as well as pharmaceutical utilities are reported. There are several methods for synthesis of diaminopyrazoles. 3,5-Diaminopyrazole and its derivatives are prepared through the reaction of malononitrile or arylhydrazononitrile with hydrazine derivatives. 3,4-Diaminopyrazoles are prepared via nitration of 3-aminopyrazole with subsequent reduction of the produced compound. The diaminopyrazoles have several applications in cosmetic and pharmaceutical industries. They also have useful utilities as a constituent in oxidative hair dyes. Conclusion: We managed to report the common methods for the synthesis of diaminoazoles with especial reference to aminopyrazoles that are prepared through the reaction of malononitrile or hydrazononitriles with hydrazine derivatives. Some important applications that include pharmaceutical utilities such as hair dye constituents are reported.
|
|
| 15. |
- Essalhi, Mohamed, et al.
(författare)
-
Improvement of nanostructured electrospun membranes for desalination by membrane distillation technology
- 2021
-
Ingår i: Desalination. - : Elsevier. - 0011-9164 .- 1873-4464. ; 510
-
Tidskriftsartikel (refereegranskat)abstract
- A systematic study is carried out to determine the optimum electrospinning preparation condition to prepare an adequate electrospun nanofibrous membrane (ENM) for direct contact membrane distillation (DCMD). A structural properties investigation of ENM was carried out because of the significant impact of its architectural structure, nanofiber diameter, inter-fiber space and ENM thickness, on DCMD performance. The morphology, hydrophobicity, mechanical properties, crystallinity and DCMD desalination were investigated. A long-term DCMD experiment (100h) was carried out using 30 g/L NaCl aqueous solution, both in the feed and permeate side of the optimum ENM membrane to evaluate its potential to produce drinkable water in case of lack of distilled water, for instance in a remote area, emergency situation, and/or portable system. In this case, drinkable water could be produced after 28 h with a permeate flux of 57.5 kg/m2.h and a salt rejection factor greater than 99.9%. Another long-term DCMD experiment (65 h) was conducted using 30 g/L NaCl aquesous solution as feed but at a higher temperature and distilled water as permeate to evaluate the desalination stability, wettability and scaling of the optimum ENM. A permeate flux of 58.5 kg/m2.h was obtained with a salt rejection factor greater than 99.9%.
|
|
| 16. |
- Essalhi, Mohamed, et al.
(författare)
-
Polyvinylidene fluoride membrane formation using carbon dioxide as a non-solvent additive for nuclear wastewater decontamination
- 2022
-
Ingår i: Chemical Engineering Journal. - : Elsevier. - 1385-8947 .- 1873-3212. ; 446:4
-
Tidskriftsartikel (refereegranskat)abstract
- Polyvinylidene fluoride (PVDF) membranes were prepared by phase inversion in the most commonly used solvents for membrane manufacture, with CO2 as a non-solvent additive. The effects of changing the polymer concentration (10, 12.5 and 15% by weight), the type of solvent (NMP, DMAc and DMF) and the coagulation bath with three levels of CO2 concentration on the phase inversion process, as well as the phase diagram, morphology and transport properties of the membranes were studied. The best performing membranes were used to desalinate salt aqueous solutions and decontaminated simulated nuclear wastewater by membrane distillation using two configurations (DCMD and AGMD). All selected membranes showed high rejection with acceptable permeate fluxes reaching an infinite decontamination factor. The proposed approach of this novel idea of using CO2 dissolved in water as a coagulation medium in the field of membranes avoids the increase of the harmful effect on the environment caused by the addition of a harsh non-solvent to the coagulation bath. It constitutes a beneficial use of carbon dioxide that reduces the negative environmental impact of membrane manufacturing and represents a decisive step towards its sustainability. Furthermore, this study highlights the potential benefits of using these membranes in DM for desalination and treatment of simulated nuclear wastewater.
|
|
| 17. |
- Ismail, Norafiqah, et al.
(författare)
-
Experimental and theoretical studies on the formation of pure β-phase polymorphs during fabrication of polyvinylidene fluoride membranes by cyclic carbonate solvents
- 2021
-
Ingår i: Green Chemistry. - : Royal Society of Chemistry. - 1463-9262 .- 1463-9270. ; 23:5, s. 2130-2147
-
Tidskriftsartikel (refereegranskat)abstract
- The use of highly toxic solvents presents significant risks to both the environment and human health. Therefore, the adoption of green solvents will be crucial for achieving sustainable membrane production. This work reports the use of inexpensive environmentally friendly biobased and biodegradable cyclic carbonate solvents, namely ethylene carbonate (EC), propylene carbonate (PC), and butylene carbonate (BC), to fabricate polyvinylidene fluoride (PVDF) membranes. The solvent dependence of the phase inversion mechanisms, morphology, crystalline structures, and polymorphism of the prepared PVDF membranes were investigated. Polymorph analysis revealed that membrane fabrication in EC or PC yielded exclusively the β-phase product, whereas PVDF membrane fabrication in BC yielded a mixture of α and β phase material. The mechanism of β-phase formation was investigated using molecular dynamics simulation and shown to depend on the extent of hydrogen bonding at the polymer–solvent interface. The PVDF membrane formed in EC exhibited the highest porosity and pure water permeability, and was therefore tested in direct contact membrane distillation (DCMD), exhibiting promising results in terms of permeate flux and salt rejection. These results suggest that large-scale production of piezoelectric PVDF membranes using green solvents should be practically feasible.
|
|
| 18. |
- Khatri, C, et al.
(författare)
-
Outcomes after perioperative SARS-CoV-2 infection in patients with proximal femoral fractures: an international cohort study
- 2021
-
Ingår i: BMJ open. - : BMJ. - 2044-6055. ; 11:11, s. e050830-
-
Tidskriftsartikel (refereegranskat)abstract
- Studies have demonstrated high rates of mortality in people with proximal femoral fracture and SARS-CoV-2, but there is limited published data on the factors that influence mortality for clinicians to make informed treatment decisions. This study aims to report the 30-day mortality associated with perioperative infection of patients undergoing surgery for proximal femoral fractures and to examine the factors that influence mortality in a multivariate analysis.SettingProspective, international, multicentre, observational cohort study.ParticipantsPatients undergoing any operation for a proximal femoral fracture from 1 February to 30 April 2020 and with perioperative SARS-CoV-2 infection (either 7 days prior or 30-day postoperative).Primary outcome30-day mortality. Multivariate modelling was performed to identify factors associated with 30-day mortality.ResultsThis study reports included 1063 patients from 174 hospitals in 19 countries. Overall 30-day mortality was 29.4% (313/1063). In an adjusted model, 30-day mortality was associated with male gender (OR 2.29, 95% CI 1.68 to 3.13, p<0.001), age >80 years (OR 1.60, 95% CI 1.1 to 2.31, p=0.013), preoperative diagnosis of dementia (OR 1.57, 95% CI 1.15 to 2.16, p=0.005), kidney disease (OR 1.73, 95% CI 1.18 to 2.55, p=0.005) and congestive heart failure (OR 1.62, 95% CI 1.06 to 2.48, p=0.025). Mortality at 30 days was lower in patients with a preoperative diagnosis of SARS-CoV-2 (OR 0.6, 95% CI 0.6 (0.42 to 0.85), p=0.004). There was no difference in mortality in patients with an increase to delay in surgery (p=0.220) or type of anaesthetic given (p=0.787).ConclusionsPatients undergoing surgery for a proximal femoral fracture with a perioperative infection of SARS-CoV-2 have a high rate of mortality. This study would support the need for providing these patients with individualised medical and anaesthetic care, including medical optimisation before theatre. Careful preoperative counselling is needed for those with a proximal femoral fracture and SARS-CoV-2, especially those in the highest risk groups.Trial registration numberNCT04323644
|
|
| 19. |
- Marto, João Pedro, et al.
(författare)
-
Safety and Outcome of Revascularization Treatment in Patients With Acute Ischemic Stroke and COVID-19: The Global COVID-19 Stroke Registry.
- 2023
-
Ingår i: Neurology. - 1526-632X. ; 100:7
-
Tidskriftsartikel (refereegranskat)abstract
- COVID-19-related inflammation, endothelial dysfunction, and coagulopathy may increase the bleeding risk and lower the efficacy of revascularization treatments in patients with acute ischemic stroke (AIS). We aimed to evaluate the safety and outcomes of revascularization treatments in patients with AIS and COVID-19.This was a retrospective multicenter cohort study of consecutive patients with AIS receiving intravenous thrombolysis (IVT) and/or endovascular treatment (EVT) between March 2020 and June 2021 tested for severe acute respiratory syndrome coronavirus 2 infection. With a doubly robust model combining propensity score weighting and multivariate regression, we studied the association of COVID-19 with intracranial bleeding complications and clinical outcomes. Subgroup analyses were performed according to treatment groups (IVT-only and EVT).Of a total of 15,128 included patients from 105 centers, 853 (5.6%) were diagnosed with COVID-19; of those, 5,848 (38.7%) patients received IVT-only and 9,280 (61.3%) EVT (with or without IVT). Patients with COVID-19 had a higher rate of symptomatic intracerebral hemorrhage (SICH) (adjusted OR 1.53; 95% CI 1.16-2.01), symptomatic subarachnoid hemorrhage (SSAH) (OR 1.80; 95% CI 1.20-2.69), SICH and/or SSAH combined (OR 1.56; 95% CI 1.23-1.99), 24-hour mortality (OR 2.47; 95% CI 1.58-3.86), and 3-month mortality (OR 1.88; 95% CI 1.52-2.33). Patients with COVID-19 also had an unfavorable shift in the distribution of the modified Rankin score at 3 months (OR 1.42; 95% CI 1.26-1.60).Patients with AIS and COVID-19 showed higher rates of intracranial bleeding complications and worse clinical outcomes after revascularization treatments than contemporaneous non-COVID-19 patients receiving treatment. Current available data do not allow direct conclusions to be drawn on the effectiveness of revascularization treatments in patients with COVID-19 or to establish different treatment recommendations in this subgroup of patients with ischemic stroke. Our findings can be taken into consideration for treatment decisions, patient monitoring, and establishing prognosis.The study was registered under ClinicalTrials.gov identifier NCT04895462.
|
|
| 20. |
- Taha, Rania H., et al.
(författare)
-
Synthesis and characterization of a symmetrically substituted cyclodiphosph(V)azane ligand (H4L') and its transition metal complexes for antimicrobial and antitumor investigation
- 2020
-
Ingår i: Egyptian Journal of Chemistry. - : Egypts Presidential Specialized Council for Education and Scientific Research. - 0449-2285 .- 2357-0245. ; 63:8, s. 3097-3107
-
Tidskriftsartikel (refereegranskat)abstract
- A NEW ligand of geminal cyclodiphosph(V)azane derivatives, 1,3-di-[N/-2,6-dimethoxyLl-pyrimidnylsulfanilamide12,4-di-IN/-2-quinoxalinylsulfanilamidel-2,4dichloroc- yelodiphosph(V)azane (H4L') was prepared. The ligand and its related complexes were characterized by different physicochemical techniques, namely; IR, UV vis, mass, 'H NMR, molar conductance, magnetic, solid reflectance, and thermal analysis The spectral data revealed that the ligand behaves as ionic in nature and coordinated to the metal ions via enolic-OH of sulphonamide group and pyrimidine N. The molar conductance data reveal that the complexes were electrolytes, while UV vis, solid reflectance and magnetic moment data have been shown that the complexes have octahedral geometry. The thermal behavior of the complexes was also studied. The ligand and its metal complexes showed a high to moderate antimicrobial activities against deferent strains of bacteria and fungi, also showed anticancer activity against colon carcinoma HCT116.
|
|
